The NHLBI SBIR/STTR Resources
Reporting : Final Progress Report Instructions for NHLBI Grantees.
NIH has released new
instructions (83 KB) for preparing your SBIR/STTR Final Progress Reports.
View the instructions (83 KB) and the
Professional Advisory Services for NHLBI Small Business Companies/
Not sure about how to make contact with the FDA? Wondering about how to protect your
intellectual property? Need advice on your commercialization plan? The Office of Translational Alliances
and Coordination has brought together a team of experts skilled in Regulatory Affairs, Intellectual Property,
and Business Development. Visit the
OTAC Resources Page for further information on these topics
and contact us to schedule a meeting.
The NIH Commercialization Assistance Program
(CAP) is a FREE specialized technical
assistance program for SBIR Phase II
awardees. CAP is designed to help promising
small life science companies develop their
commercial businesses and transition their
SBIR-developed technologies into the
marketplace. CAP applications are accepted
once per year, usually in the Fall. We will
post more information here when the program
is again selecting applications.
Learn more about CAP
Niche Assessment Program
The NIH SBIR Niche Assessment Program is a FREE
nationwide program funded by the NIH to help jump-start
an SBIR Phase I awardee's commercialization efforts.
Services are provided by Foresight Science and
Technology of Providence, RI.
Technology Niche Analyses™ (TNA™) are provided by
Foresight for one hundred (100) NIH SBIR Phase I
awardees. These analyses assess potential
applications for a technology and then for one
viable application, it provides an assessment of
- needs and concerns of end-users;
- competing technologies and competing
- competitive advantage of the SBIR-developed
- market size and potential market share (may
include national and/or global markets);
- barriers to market entry (may include but
not limited to pricing, competition, government
regulations, manufacturing challenges, capital
- market drivers;
- status of market and industry trends;
- potential customers, licensees, investors,
or other commercialization partners; and,
- the price customers are likely to pay
Learn more about NAP
The FDA provides the following education materials:
For more Regulatory information, please visit the
OTAC Resources Page.
Intellectual Property Assessment Tool
The USPTO offers help with patent related
issues, including assistance, training and services.
For more IP information, please visit the
OTAC Resources Page.
Last Updated September 2014